Drug Shortage Report for ROVAMYCINE 250 CAPSULE 750000 UNIT

Last updated on 2018-05-22 History
Report ID 19341
Drug Identification Number 01927825
Brand name ROVAMYCINE 250 CAPSULE 750000 UNIT
Common or Proper name Spiramycin capsules
Company Name ODAN LABORATORIES LTD
Market Status DORMANT
Active Ingredient(s) SPIRAMYCIN
Strength(s) 750000UNIT
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 50
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-02-01
Actual start date 2018-01-31
Estimated end date 2018-05-18
Actual end date 2018-05-18
Shortage status Resolved
Updated date 2018-05-22
Company comments
Health Canada comments
Tier 3 Status No
Company contact information info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-05-22 French Compare
v10 2018-05-22 English Compare
v9 2018-05-15 French Compare
v8 2018-05-15 English Compare
v7 2018-04-16 French Compare
v6 2018-04-16 English Compare
v5 2018-02-01 English Compare
v4 2018-01-31 French Compare
v3 2018-01-31 English Compare
v2 2017-08-14 French Compare
v1 2017-08-14 English Compare

Showing 1 to 11 of 11